# Manganese-Enhanced Magnetic Resonance Imaging of MyOcardial injuRY in COVID 19 (COVID-19)

> **NCT04625075** · — · COMPLETED · sponsor: **University of Edinburgh** · enrollment: 54 (actual)

## Conditions studied

- Covid19

## Interventions

- **DIAGNOSTIC_TEST:** Cardiac MRI
- **DIAGNOSTIC_TEST:** Cardiac CT
- **DIAGNOSTIC_TEST:** Electrocardiogram (ECG)
- **DIAGNOSTIC_TEST:** Blood samples

## Key facts

- **NCT ID:** NCT04625075
- **Lead sponsor:** University of Edinburgh
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-06-10
- **Primary completion:** 2021-06-10
- **Final completion:** 2022-02-03
- **Target enrollment:** 54 (ACTUAL)
- **Last updated:** 2024-05-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04625075

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04625075, "Manganese-Enhanced Magnetic Resonance Imaging of MyOcardial injuRY in COVID 19 (COVID-19)". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04625075. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*